Observational Study of First-Time Ischemic Stroke or TIA in Adults Aged 18 to 50
Investigating Blood Clotting, Inflammation, and Vessel Health
Led by Radboud University Medical Center · Updated on 2023-05-11
280
Participants Needed
6
Research Sites
521 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the causes and outcomes of ischemic stroke or transient ischemic attack TIA in young adults aged 18 to 50 years. This observational study aims to understand how blood clotting, inflammation, and damage to blood vessel linings contribute to stroke in this age group. The study also explores how these factors affect the risk of stroke recurrence and bleeding complications over time.
The study includes two groups patients aged 18 to 50 who have had a first-ever ischemic stroke or TIA, and healthy controls of the same age range without cardiovascular disease. Researchers will collect blood samples at the start and after three months to analyze clotting and inflammation markers. Participants will also undergo 3 Tesla MRI scans to assess blood vessel walls and complete questionnaires about possible stroke triggers.
Participants will be involved in evaluations at baseline and three months, including blood tests for coagulation and inflammation, MRI scans, and questionnaires. Researchers will track participants for up to 10 years to monitor recurrent cardiovascular events, venous thrombosis, malignancy, bleeding complications, and overall survival. The study will compare findings between stroke patients and healthy controls to better understand stroke mechanisms in young adults.
CONDITIONS
Brief Title
Observational Dutch Young Symptomatic StrokE studY - nEXT
Research Team
F
Frank-Erik De Leeuw, Prof.
J
Janneke Spiegelenberg, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients with a first-ever transient ischemic attack (TIA) or acute ischemic stroke aged between 18 and 50 years old
Acute stroke defined as neurological deficit lasting more than 24 hours with imaging confirmation
TIA defined as neurological deficit lasting less than 24 hours with MRI confirmation of ischemia
Kidney function estimated glomerular filtration rate (eGFR) greater than 30 ml/min
You will not qualify if you...
History of clinical TIA, ischemic stroke or intracerebral hemorrhage
Intracerebral hemorrhage caused by trauma, known aneurysm or intracerebral malignancy
Venous infarction, retinal infarction or amourosis fugax
Inadequate Dutch language skills to provide informed consent and participate in follow-up
Contraindication for 3 Tesla MRI
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Baseline visit
Participants undergo baseline assessments including blood biomarker measurements and vessel wall imaging with 3T MRI.
1 visit (in-person)
Surveillance
Duration - Up to 10 years
Participants are observed for recurrent cardiovascular events, venous thrombotic events, malignancy, bleeding complications, and death over time.
1 visit at 3 months and periodic follow-up visits during 10 years
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Risk Prediction Study for Patients with Structural, Rhythm, or Inflammatory Cardiovascular Diseases
Study of Perfect Heartio Drink to Support Heart and Blood Vessel Health in Adults
Early Detection of Type 2 Diabetes and Cardiovascular Risks Using CUORE and FINDRISC Tools in Adults Turning 50 in Marche Region
100-Year Human Aging Study Observing Multi-System Health to Predict Mortality and Aging Outcomes
Imaging Carotid Artery Plaques Using 18F FDG and 68Ga FAPI PETMR to Study Plaque Vulnerability and Stroke Risk
Observational Cohort Study of Biomarkers and Health Outcomes in Adults with Hypertension in Guangdong Province
Evaluating a Digital Lifestyle Program in Primary Healthcare to Improve Heart Health and Prevent Cardiovascular Disease in Adults Aged 40 to 60
Evaluating Two Dosages of Bevifibatide Injection for Treating Acute Ischemic Stroke Without Large Vessel Blockage in Adults
Long-Term Study of How Menopause Affects Heart and Blood Vessel Health in Women Aged 40 to 61
Observational Study of Safety and Performance of the Polymer-Free Sirolimus Eluting Vivo ISAR Coronary Stent
in Patients With Cardiovascular Disease Receiving Short Dual Antiplatelet Therapy
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Role of inflammation and haemostasis on aetiology and prognosis in young patients with ischaemic stroke: study protocol of the Observational Dutch Young Symptomatic StrokE study-EXTended (ODYSSEY-nEXT) - a multicentre prospective cohort study.
Janneke P Spiegelenberg, Esmée Verburgt, Heleen den Hertog...